Difference between revisions of "CD10"
Jump to navigation
Jump to search
| Line 2: | Line 2: | ||
==Positive== | ==Positive== | ||
===Benign=== | |||
*Benign liver.<ref name=pmid14755758/> | *Benign liver.<ref name=pmid14755758/> | ||
===Lymphoma=== | ===Lymphoma=== | ||
*[[Follicular lymphoma]]. | *[[Follicular lymphoma]]. | ||
*[[Diffuse large B-cell lymphoma]]. | *[[Diffuse large B-cell lymphoma]]. | ||
===Other tumours=== | |||
*[[Clear cell renal cell carcinoma]]. | |||
*[[Hepatocellular carcinoma]].<ref name=pmid14755758>{{Cite journal | last1 = Lin | first1 = F. | last2 = Abdallah | first2 = H. | last3 = Meschter | first3 = S. | title = Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. | journal = Diagn Cytopathol | volume = 30 | issue = 2 | pages = 92-7 | month = Feb | year = 2004 | doi = 10.1002/dc.10419 | PMID = 14755758 }}</ref> | |||
==See also== | ==See also== | ||
Revision as of 17:35, 20 March 2015
CD10 is a commonly used immunostain.
Positive
Benign
- Benign liver.[1]